• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不涉及骨骼的甲鳞状细胞癌功能性手术与截肢术后的复发率:一项系统评价。

Recurrence rates after functional surgery versus amputation for nail squamous cell carcinoma not involving the bone: A systematic review.

作者信息

Wong Hoi-Shiwn, Li Fang, Jiang Jia-Yi, Huang Shu-Dai, Ji Xiang, Zhu Ping, Wang Da-Guang

机构信息

Department of Dermatology and Venereology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

Department of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

出版信息

Indian J Dermatol Venereol Leprol. 2025 Jan-Feb;91(1):31-39. doi: 10.25259/IJDVL_912_2023.

DOI:10.25259/IJDVL_912_2023
PMID:39152816
Abstract

Background Nail unit squamous cell carcinoma (nSCC) is a malignant subungual tumour. Although it has a low risk of metastasis and mortality, the tumour has a significant local recurrence rate. There is insufficient data to determine whether functional surgery is less effective than amputation for nSCC that does not involve the bone. Objectives We aimed to investigate existing data on the outcomes of functional surgery and amputation for nSCC without bone invasion. Materials and Methods We carried out an extensive search in PubMed, Embase, Cochrane Library, Web of Science, and Scopus for appropriate English-language academic papers, starting with the creation of individual resources until February 23, 2023. The main outcome was local recurrence. Initially, 2191 studies related to nSCC were selected. Information from every research study was retrieved and subdivided, comprising the year of publication, period, number of patients, age, gender distribution, tumour stage, type of intervention, number of recurrences, and follow-up period. Results Ten independent studies (319 lesions) were finally selected. Mohs micrographic surgery was the most reported surgical modality, followed by wide surgical excision and amputation. Local recurrence rates between Mohs micrographic surgery, wide surgical excision and amputation treatment were nearly identical. Other surgical methods included limited surgical excision, partial ablation, and limited excision until the clearing of margins, with recurrence rates up to 50%. Conclusions Given the functional impairment and psychological distress associated with phalanx amputation, functional surgery, including Mohs micrographic surgery and wide surgical excision , should be the preferred therapy for nSCC without bone involvement. Amputation should remain the preferred therapy for nSCC that involves the bone. Partial excision should be avoided. Further studies on whether Mohs micrographic surgery or wide surgical excision is a better option for nSCC not involving the bone are required.

摘要

背景 甲单位鳞状细胞癌(nSCC)是一种恶性甲下肿瘤。尽管其转移和死亡率风险较低,但该肿瘤的局部复发率较高。目前尚无足够数据确定对于不累及骨骼的nSCC,功能性手术是否比截肢手术效果差。目的 我们旨在研究关于不累及骨骼的nSCC进行功能性手术和截肢手术结果的现有数据。材料与方法 我们在PubMed、Embase、Cochrane图书馆、科学网和Scopus中进行了广泛检索,以查找合适的英文医学论文,检索起始于各数据库创建之时,截至2023年2月23日。主要结局为局部复发。最初,共筛选出2191项与nSCC相关的研究。提取并细分每项研究的信息,包括发表年份、时间段、患者数量、年龄、性别分布、肿瘤分期、干预类型、复发次数和随访期。结果 最终筛选出10项独立研究(共319个病灶)。莫氏显微描记手术是报道最多的手术方式,其次是广泛手术切除和截肢手术。莫氏显微描记手术、广泛手术切除和截肢手术的局部复发率几乎相同。其他手术方法包括有限手术切除、部分消融以及切缘阴性前的有限切除,复发率高达50%。结论 鉴于指骨截肢会导致功能障碍和心理困扰,对于不累及骨骼的nSCC,包括莫氏显微描记手术和广泛手术切除在内的功能性手术应作为首选治疗方法。对于累及骨骼的nSCC,截肢仍应作为首选治疗方法。应避免部分切除。对于不累及骨骼的nSCC,莫氏显微描记手术或广泛手术切除哪种是更好的选择,还需要进一步研究。

相似文献

1
Recurrence rates after functional surgery versus amputation for nail squamous cell carcinoma not involving the bone: A systematic review.不涉及骨骼的甲鳞状细胞癌功能性手术与截肢术后的复发率:一项系统评价。
Indian J Dermatol Venereol Leprol. 2025 Jan-Feb;91(1):31-39. doi: 10.25259/IJDVL_912_2023.
2
Interventions for melanoma in situ, including lentigo maligna.原位黑色素瘤的干预措施,包括恶性雀斑样痣。
Cochrane Database Syst Rev. 2014 Dec 19;2014(12):CD010308. doi: 10.1002/14651858.CD010308.pub2.
3
Squamous cell carcinoma of the nail in patients with Fitzpatrick phototypes IV-VI: a systematic review.菲茨帕特里克皮肤类型 IV-VI 患者的甲下鳞状细胞癌:系统评价。
Int J Dermatol. 2024 Oct;63(10):1302-1307. doi: 10.1111/ijd.17237. Epub 2024 May 12.
4
Surgical excision methods for skin cancer involving the nail unit: A systematic review.涉及甲单位的皮肤癌手术切除方法:一项系统评价。
Cochrane Evid Synth Methods. 2023 Oct 16;1(8):e12026. doi: 10.1002/cesm.12026. eCollection 2023 Oct.
5
Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: A systematic review and meta-analysis.显微镜手术与传统切除术降低基底细胞癌和鳞状细胞癌复发率的疗效比较:系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2024 Jun;38(6):1058-1069. doi: 10.1111/jdv.19743. Epub 2023 Dec 20.
6
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.治疗寻常型外阴上皮内瘤变的医学和外科干预措施。
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD011837. doi: 10.1002/14651858.CD011837.pub2.
7
Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent).不同治疗方式对成人卵巢颗粒细胞瘤(原发性和复发性)治疗的有效性
Cochrane Database Syst Rev. 2014 Apr 21;2014(4):CD006912. doi: 10.1002/14651858.CD006912.pub2.
8
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究(StARDISC):一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.